HROW
HARROW, INC.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$33.08
−0.15%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- $0.16
- Revenue estimate
- $99.1M
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.46
- EPS estimate
- -$0.18
- Revenue actual
- $70.7M
- Revenue estimate
- $70.4M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -519.1%
- Revenue beats (12Q)
- 5
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $54
- PT range
- $45 – $63
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.18 | -$0.46 | Miss -157.34% | $70.7M |
| May 12, 2026 | -$0.43 | -$0.63 | Miss -46.51% | $44.2M |
| May 8, 2025 | $0.02 | -$0.38 | Miss -2000.00% | $47.8M |
| Mar 27, 2025 | $0.11 | $0.25 | Beat 127.27% | $66.8M |
| Mar 19, 2024 | -$0.05 | -$0.27 | Miss -455.56% | $36.4M |
| Nov 13, 2023 | -$0.02 | -$0.09 | Miss -467.82% | $34.3M |
| May 11, 2023 | -$0.06 | -$0.03 | Beat 50.00% | $26.1M |
| Mar 23, 2023 | -$0.15 | $0.07 | Beat 146.67% | $20.3M |
| Nov 14, 2022 | -$0.00 | -$0.06 | Miss -9577.42% | $22.8M |
| May 5, 2022 | $0.01 | $0.03 | Beat 185.71% | $22.1M |
| Mar 10, 2022 | $0.08 | -$0.01 | Miss -112.50% | $20.2M |
| Mar 8, 2021 | $0.04 | $0.04 | Beat 14.29% | $14.6M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026